Speech-Language Pathologists in Annapolis, MD Accepting Medicare

169 Speech-Language Pathologists found. Showing 161 - 169

Mrs. Coni Jean Giannini, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Ms. Patricia Denver Yactayo, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Erin R Singlemann, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Erika Anne Deckard, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Sarah Councill, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Rd, Annapolis, MD 21401 Phone: 410-222-5000

Speech Matters, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 99 Cathedral St, Annapolis, MD 21401 Phone: 410-295-1616

Anusha Sivalingam, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1000

Lauren Johnson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2644 Riva Road, Annapolis, MD 21401 Phone: 410-222-5000

Jacob Glaser Donkin, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1419 Forest Dr Ste 206, Annapolis, MD 21403 Phone: 410-280-9788

News Archive

FDA grants Orphan Drug Designation to TxCell's Col-Treg for treatment of autoimmune uveitis

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation (ODD) to TxCell's Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of chronic non-infectious uveitis.

Princeton researchers match images of brain activity with complex thought

In an effort to understand what happens in the brain when a person reads or considers such abstract ideas as love or justice, Princeton researchers have for the first time matched images of brain activity with categories of words related to the concepts a person is thinking about. The results could lead to a better understanding of how people consider meaning and context when reading or thinking.

Largest study ever to look at possible heart risks with ADHD medications

Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.

U-M researchers to evaluate Medicaid expansion in Michigan

Since its launch in April, 481,863 Michiganders have signed up for a new Medicaid health insurance option offered by the state, called the Healthy Michigan Plan. Now, University of Michigan researchers will study how well the new plan works, and advise the state government on how well it's living up to what lawmakers intended.

Today's Op-Ed selections: Medicare, Medicaid and the Constitution

My patient had just been the recipient of a rare and highly valued medical commodity, a treatment that is as quantifiable in its effects as the milligrams of a medication or the number of stitches in a wound: Time (Daphne Miller, 9/15).

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9(current)